Literature DB >> 24037475

Prevalence of rubella IgG antibodies among pregnant women in Zaria, Nigeria.

Mohammed-Durosinlorun Amina1, Shittu Oladapo, Sadauki Habib, Olayinka Adebola, Kolawole Bimbo, Adejo Daniel.   

Abstract

Rubella is a vaccine-preventable viral infection which in pregnancy can lead to foetal wastage and congenital malformations. A rubella IgG serosurvey of 430 consenting pregnant women attending the antenatal clinic was conducted at the Ahmadu Bello University Teaching Hospital, Zaria between 1 May 2007 and 29 February 2008. Questionnaires were also used to assess their level of awareness and pregnancy outcomes noted. Of the 430 serum samples tested, 421 (97.9%) were positive and 9 (2.1%) were negative for rubella IgG antibody. Differences in sociodemographic factors were of little significance between the groups and awareness of the infection was low. This high prevalence suggests that a sustained viral circulation exists in children and infection occurs early in infancy hence a high level of immunity exists in pregnant women with low levels of complications. In the absence of mass vaccination, all seronegative women should be vaccinated after delivery.

Entities:  

Year:  2010        PMID: 24037475     DOI: 10.1016/j.inhe.2010.03.004

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   2.473


  6 in total

1.  Sero-prevalence of rubella among pregnant women in Sub-Saharan Africa: a meta-analysis.

Authors:  Zemenu Yohannes Kassa; Siraj Hussen; Solomon Asnake
Journal:  Hum Vaccin Immunother       Date:  2020-03-20       Impact factor: 3.452

2.  Seroprevalence of rubella-specific IgM and IgG antibodies among pregnant women seen in a tertiary hospital in Nigeria.

Authors:  Okikiola M Olajide; Maryam Aminu; Abdullahi J Randawa; Daniel S Adejo
Journal:  Int J Womens Health       Date:  2015-01-06

3.  The risk factors of exposure to rubella among pregnant women in Zaria 2013.

Authors:  Aishatu Bintu Gubio; Aisha Indo Mamman; Muhammad Abdul; Adebola Tolulope Olayinka
Journal:  Pan Afr Med J       Date:  2019-01-21

Review 4.  Serological makers of rubella infection in Africa in the pre vaccination era: a systematic review.

Authors:  Mariam M Mirambo; Mtebe Majigo; Said Aboud; Uwe Groß; Stephen E Mshana
Journal:  BMC Res Notes       Date:  2015-11-25

5.  Rubella virus infection and associated factors among pregnant women attending the antenatal care clinics of public hospitals in Hawassa City, Southern Ethiopia: a cross-sectional study.

Authors:  Biniam Tamirat; Siraj Hussen; Techalew Shimelis
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

6.  The Screening of Rubella Virus, Cytomegalovirus, Hepatitis B Virus, and Toxoplasma gondii Antibodies in Prepregnancy and Reproductive-Age Women in Tabriz, Iran.

Authors:  Edris Nabizadeh; Anahita Ghotaslou; Behnaz Salahi; Reza Ghotaslou
Journal:  Infect Dis Obstet Gynecol       Date:  2022-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.